A special thank you to SEB, redalpine, Range Rover, The Macallan, and Thora Vingrd
M., Giorcelli, G., Siliprandi, N
Vinculin run on the same blot was used as a loading control
At first glance, it looks like the patent was unnecessary since semaglutide was already protected by data exclusivity, and both were ending in early 2026
Common Side Effects for Both Compounds: The high prevalence of gastrointestinal adverse events with each compound individually suggests that combining them could potentially result in: More severe nausea and vomiting episodes Higher discontinuation rates Reduced treatment adherence Potential nutritional deficiencies from excessive appetite suppression Dehydration risks from combined GI effects Health and wellness professionals must understand these risks when evaluating any experimental protocols involving cagrilintide alongside other metabolic peptides
I also became gluten intolerant so beer and whiskey were out too
